KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Change in Taxes (2019 - 2026)

AbbVie has reported Change in Taxes over the past 7 years, most recently at $646.0 million for Q4 2025.

  • Quarterly Change in Taxes rose 135.83% to $646.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$762.0 million through Dec 2025, up 76.25% year-over-year, with the annual reading at -$762.0 million for FY2025, 76.25% up from the prior year.
  • Change in Taxes was $646.0 million for Q4 2025 at AbbVie, up from -$411.0 million in the prior quarter.
  • Over five years, Change in Taxes peaked at $646.0 million in Q4 2025 and troughed at -$1.8 billion in Q2 2024.
  • The 5-year median for Change in Taxes is $42.0 million (2023), against an average of -$260.3 million.
  • Year-over-year, Change in Taxes tumbled 5892.31% in 2021 and then soared 545.45% in 2022.
  • A 5-year view of Change in Taxes shows it stood at -$662.0 million in 2021, then soared by 154.08% to $358.0 million in 2022, then increased by 14.8% to $411.0 million in 2023, then tumbled by 538.69% to -$1.8 billion in 2024, then soared by 135.83% to $646.0 million in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Change in Taxes are $646.0 million (Q4 2025), -$411.0 million (Q3 2025), and -$1.4 billion (Q2 2025).